日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study

索拉非尼持续给药联合动脉化疗栓塞治疗肝细胞癌患者:I 期研究结果

Jean-François Dufour, Hanno Hoppe, Markus H Heim, Beat Helbling, Olivier Maurhofer, Zsolt Szucs-Farkas, Ralph Kickuth, Markus Borner, Daniel Candinas, Bettina Saar